[A new bronchospasmolytic].
D062365:Aminobenzoates / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001986:Bronchial Spasm / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002415:Cats; D003510:Cyclohexanes / Q000627:therapeutic use; D004983:Ethanolamines / Q000627:therapeutic use*; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D007267:Injections; D007275:Injections, Intravenous; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use; D010627:Phenethylamines / Q000627:therapeutic use*; D010636:Phenols / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use; D013997:Time Factors
D062365:Aminobenzoates; D001993:Bronchodilator Agents; D003510:Cyclohexanes; D004983:Ethanolamines; D010627:Phenethylamines; D010636:Phenols; D013566:Sympathomimetics; D009921:Metaproterenol
Uber ein neues Bronchospasmolytikum.